Review



pima cd4 point-of-care assays  (Abbott Laboratories)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Abbott Laboratories pima cd4 point-of-care assays
    Pima Cd4 Point Of Care Assays, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pima cd4 point-of-care assays/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    pima cd4 point-of-care assays - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    pima cd4 point-of-care assays  (Abbott Laboratories)
    90
    Abbott Laboratories pima cd4 point-of-care assays
    Pima Cd4 Point Of Care Assays, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pima cd4 point-of-care assays/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    pima cd4 point-of-care assays - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    pima cd4 analyzer  (Abbott Laboratories)
    90
    Abbott Laboratories pima cd4 analyzer
    Pima Cd4 Analyzer, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pima cd4 analyzer/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    pima cd4 analyzer - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    pima cd4 analyser  (Abbott Laboratories)
    90
    Abbott Laboratories pima cd4 analyser
    Pima Cd4 Analyser, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pima cd4 analyser/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    pima cd4 analyser - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    pima poc cd4 test system  (Abbott Laboratories)
    90
    Abbott Laboratories pima poc cd4 test system
    DIPT trial participant characteristics at baseline, overall and by study arm, limited to n = 619 participants with alcohol use and/or HIV viral load data at 12 months.
    Pima Poc Cd4 Test System, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pima poc cd4 test system/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    pima poc cd4 test system - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    pima cd4 platforms  (Abbott Laboratories)
    90
    Abbott Laboratories pima cd4 platforms
    DIPT trial participant characteristics at baseline, overall and by study arm, limited to n = 619 participants with alcohol use and/or HIV viral load data at 12 months.
    Pima Cd4 Platforms, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pima cd4 platforms/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    pima cd4 platforms - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    pima cd4 automatic test  (Abbott Laboratories)
    90
    Abbott Laboratories pima cd4 automatic test
    DIPT trial participant characteristics at baseline, overall and by study arm, limited to n = 619 participants with alcohol use and/or HIV viral load data at 12 months.
    Pima Cd4 Automatic Test, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pima cd4 automatic test/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    pima cd4 automatic test - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    pima cd4 abbott/pantech (pty)  (Abbott Laboratories)
    90
    Abbott Laboratories pima cd4 abbott/pantech (pty)
    Sociodemographic, biological, and clinical characteristics of the study population.
    Pima Cd4 Abbott/Pantech (Pty), supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pima cd4 abbott/pantech (pty)/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    pima cd4 abbott/pantech (pty) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    pima™ cd4 cartridge  (Abbott Laboratories)
    90
    Abbott Laboratories pima™ cd4 cartridge
    Baseline characteristics of the study population.
    Pima™ Cd4 Cartridge, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pima™ cd4 cartridge/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    pima™ cd4 cartridge - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    DIPT trial participant characteristics at baseline, overall and by study arm, limited to n = 619 participants with alcohol use and/or HIV viral load data at 12 months.

    Journal: eClinicalMedicine

    Article Title: Alcohol use and HIV suppression after completion of financial incentives for alcohol abstinence and isoniazid adherence: a randomized controlled trial

    doi: 10.1016/j.eclinm.2024.103045

    Figure Lengend Snippet: DIPT trial participant characteristics at baseline, overall and by study arm, limited to n = 619 participants with alcohol use and/or HIV viral load data at 12 months.

    Article Snippet: CD4 + cell count tests were done at baseline using the BD FACS Presto (TM), PIMA POC CD4 test system (Alere Inc., Waltham, MA).

    Techniques:

    Sociodemographic, biological, and clinical characteristics of the study population.

    Journal: Frontiers in Medicine

    Article Title: Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study

    doi: 10.3389/fmed.2024.1457501

    Figure Lengend Snippet: Sociodemographic, biological, and clinical characteristics of the study population.

    Article Snippet: Sociodemographic data, immunological (CD4), and virological (plasma viral load, PVL) responses were measured at enrolment (T0), 6-months (T1), and 12-months (T2) using PIMA CD4 (Abbott/Pantech (Pty) Ltd) and Abbott Applied Biosystem platform (Real-Time PCR m2000RT) respectively.

    Techniques: Biomarker Discovery

    Exploratory analysis of CD4+ count dynamics in adolescents living with HIV: impact of gender (sex), educational level, and study site characteristics .

    Journal: Frontiers in Medicine

    Article Title: Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study

    doi: 10.3389/fmed.2024.1457501

    Figure Lengend Snippet: Exploratory analysis of CD4+ count dynamics in adolescents living with HIV: impact of gender (sex), educational level, and study site characteristics .

    Article Snippet: Sociodemographic data, immunological (CD4), and virological (plasma viral load, PVL) responses were measured at enrolment (T0), 6-months (T1), and 12-months (T2) using PIMA CD4 (Abbott/Pantech (Pty) Ltd) and Abbott Applied Biosystem platform (Real-Time PCR m2000RT) respectively.

    Techniques:

    Median CD4+ count across study population characteristics.

    Journal: Frontiers in Medicine

    Article Title: Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study

    doi: 10.3389/fmed.2024.1457501

    Figure Lengend Snippet: Median CD4+ count across study population characteristics.

    Article Snippet: Sociodemographic data, immunological (CD4), and virological (plasma viral load, PVL) responses were measured at enrolment (T0), 6-months (T1), and 12-months (T2) using PIMA CD4 (Abbott/Pantech (Pty) Ltd) and Abbott Applied Biosystem platform (Real-Time PCR m2000RT) respectively.

    Techniques:

    CD4+ count patterns among adolescents living with HIV: influence of self-reported adherence, adolescence age ranges, and follow-up period.

    Journal: Frontiers in Medicine

    Article Title: Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study

    doi: 10.3389/fmed.2024.1457501

    Figure Lengend Snippet: CD4+ count patterns among adolescents living with HIV: influence of self-reported adherence, adolescence age ranges, and follow-up period.

    Article Snippet: Sociodemographic data, immunological (CD4), and virological (plasma viral load, PVL) responses were measured at enrolment (T0), 6-months (T1), and 12-months (T2) using PIMA CD4 (Abbott/Pantech (Pty) Ltd) and Abbott Applied Biosystem platform (Real-Time PCR m2000RT) respectively.

    Techniques:

    CD4+ count dynamics in adolescents living with HIV: effect of clinical, virological, and antiretroviral treatment regimen characteristics.

    Journal: Frontiers in Medicine

    Article Title: Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study

    doi: 10.3389/fmed.2024.1457501

    Figure Lengend Snippet: CD4+ count dynamics in adolescents living with HIV: effect of clinical, virological, and antiretroviral treatment regimen characteristics.

    Article Snippet: Sociodemographic data, immunological (CD4), and virological (plasma viral load, PVL) responses were measured at enrolment (T0), 6-months (T1), and 12-months (T2) using PIMA CD4 (Abbott/Pantech (Pty) Ltd) and Abbott Applied Biosystem platform (Real-Time PCR m2000RT) respectively.

    Techniques:

    Correlation analysis of CD4+ count dynamics in adolescent HIV patients: assessing associations with age at HIV diagnosis, age, and duration of treatment.

    Journal: Frontiers in Medicine

    Article Title: Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study

    doi: 10.3389/fmed.2024.1457501

    Figure Lengend Snippet: Correlation analysis of CD4+ count dynamics in adolescent HIV patients: assessing associations with age at HIV diagnosis, age, and duration of treatment.

    Article Snippet: Sociodemographic data, immunological (CD4), and virological (plasma viral load, PVL) responses were measured at enrolment (T0), 6-months (T1), and 12-months (T2) using PIMA CD4 (Abbott/Pantech (Pty) Ltd) and Abbott Applied Biosystem platform (Real-Time PCR m2000RT) respectively.

    Techniques: Biomarker Discovery

    Multivariate linear regression for CD4+ count with and without study site as random effect.

    Journal: Frontiers in Medicine

    Article Title: Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study

    doi: 10.3389/fmed.2024.1457501

    Figure Lengend Snippet: Multivariate linear regression for CD4+ count with and without study site as random effect.

    Article Snippet: Sociodemographic data, immunological (CD4), and virological (plasma viral load, PVL) responses were measured at enrolment (T0), 6-months (T1), and 12-months (T2) using PIMA CD4 (Abbott/Pantech (Pty) Ltd) and Abbott Applied Biosystem platform (Real-Time PCR m2000RT) respectively.

    Techniques: Biomarker Discovery

    Baseline characteristics of the study population.

    Journal: Biomedical Reports

    Article Title: Identification of cytokine signatures in HIV‑infected individuals with and without Mycobacterium tuberculosis co‑infection

    doi: 10.3892/br.2024.1819

    Figure Lengend Snippet: Baseline characteristics of the study population.

    Article Snippet: PIMA™ CD4 cartridge was inserted immediately into the Alere PIMA CD4 analyzer (Alere, Inc.) and CD4 + cell count was automatically calculated.

    Techniques:

    Cytokine production stratified by CD4 count <350 cells/µl.

    Journal: Biomedical Reports

    Article Title: Identification of cytokine signatures in HIV‑infected individuals with and without Mycobacterium tuberculosis co‑infection

    doi: 10.3892/br.2024.1819

    Figure Lengend Snippet: Cytokine production stratified by CD4 count <350 cells/µl.

    Article Snippet: PIMA™ CD4 cartridge was inserted immediately into the Alere PIMA CD4 analyzer (Alere, Inc.) and CD4 + cell count was automatically calculated.

    Techniques:

    Cytokine production stratified by CD4 count >350 cells/µl.

    Journal: Biomedical Reports

    Article Title: Identification of cytokine signatures in HIV‑infected individuals with and without Mycobacterium tuberculosis co‑infection

    doi: 10.3892/br.2024.1819

    Figure Lengend Snippet: Cytokine production stratified by CD4 count >350 cells/µl.

    Article Snippet: PIMA™ CD4 cartridge was inserted immediately into the Alere PIMA CD4 analyzer (Alere, Inc.) and CD4 + cell count was automatically calculated.

    Techniques:

    IL-17A, IFN-γ, TNF, IL-10, IL-6, IL-4 and IL-2 levels in HIV-ATB, HIV-LTB and HIV in patients with CD4 + count <350 cells/µl. * P<0.05 and ** P<0.01. HIV, human immunodeficiency virus; LTB, latent tuberculosis; ATB, active tuberculosis; ns, not significant.

    Journal: Biomedical Reports

    Article Title: Identification of cytokine signatures in HIV‑infected individuals with and without Mycobacterium tuberculosis co‑infection

    doi: 10.3892/br.2024.1819

    Figure Lengend Snippet: IL-17A, IFN-γ, TNF, IL-10, IL-6, IL-4 and IL-2 levels in HIV-ATB, HIV-LTB and HIV in patients with CD4 + count <350 cells/µl. * P<0.05 and ** P<0.01. HIV, human immunodeficiency virus; LTB, latent tuberculosis; ATB, active tuberculosis; ns, not significant.

    Article Snippet: PIMA™ CD4 cartridge was inserted immediately into the Alere PIMA CD4 analyzer (Alere, Inc.) and CD4 + cell count was automatically calculated.

    Techniques: Virus